Xihua Cao

Title: Xihua Cao: Innovator in Retinoid X Receptor Research

Introduction

Xihua Cao is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biomedical research, particularly in understanding the role of Retinoid X Receptor (RXR) in various diseases. His innovative work has led to the development of methods that can potentially transform treatment approaches for conditions affected by RXR apoptosis.

Latest Patents

Xihua Cao holds a patent titled "Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization." This invention relates to methods for identifying agents useful for the treatment of diseases and pathological conditions affected by RXR apoptosis. The patent also encompasses methods for treating these diseases and includes compositions that are beneficial in the study and treatment of conditions influenced by RXR apoptosis. He has 1 patent to his name.

Career Highlights

Cao is affiliated with the Burnham Institute, where he conducts his research. His work at the institute has positioned him as a key figure in the exploration of RXR's role in cellular processes and disease mechanisms. His research has implications for developing new therapeutic strategies.

Collaborations

Xihua Cao has collaborated with notable colleagues, including Xiao-kun Zhang and Wen K Liu. These collaborations have enhanced the scope and impact of his research, contributing to advancements in the understanding of RXR-related pathways.

Conclusion

Xihua Cao's innovative research on Retinoid X Receptor has the potential to lead to significant advancements in medical treatments. His contributions to the field are noteworthy and continue to inspire further exploration in RXR-related therapies.